Mangione pleaded guilty to stalking charges in the killing of UnitedHealthcare CEO Brian Thompson, and could face life in prison.
Revised rules for opioid addiction treatment have led to more patient retention, survey shows, though adoption isn't uniform.
Trump administration ban on using federal funds for young people's gender-affirming treatments stands on firmer legal ground, experts say.
Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.
Valisure maintained U.S. Pharmacopeia used a 2023 white paper as part of a bid to portray its own testing methods as “inherently and universally safe."
The rise of wearables could allow health insurance companies to treat human bodies like cars.
The $7 billion health software company halted a program that paid for referrals to new customers, according to emails obtained by STAT.
Play: What's the word? Test your knowledge with today's mini crossword
